Neurocrine Biosciences Acquires Soleno Therapeutics
Neurocrine Biosciences acquired Soleno Therapeutics for $2.9B. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Neurocrine Biosciences
- Acquired Company
- Soleno Therapeutics
- Price
- $2.9B
- Acquisition Type
- Merger
- Announced
- April 6, 2026
Canonical: https://fsome.com/acquisitions/neurocrine-biosciences-acquires-soleno-therapeutics-17235295 · For the full deal terms, timeline, and press references, please enable JavaScript.